Status: Not yet recruiting
A Study to Evaluate the Safety and Efficacy of Multiple Dose of STSP-0902 in Patients With Oligozoospermia and/or Asthenozoospermia.
This is a Phase 2, randomized, double-blind, placebo-controlled, multiple dose study to evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of STSP-0902 in Patients with Oligozoospermia and/or Asthenozoospermia.
Participants needed: 72
Trial details
Phase: Phase 2Age: 18-50Biological sex: MaleType: InterventionalSponsor: Staidson (Beijing) Biopharmaceuticals Co., LtdUpdated: Sep 22, 2026Locations: 1
Eligibility criteria
Male volunteers, aged between 18 and 50 years [+3]
Oligospermia and/or asthenospermia with identifiable etiologies, such as reprodu... [+12]